Back to the main directory
Company Analysis / Equity
- HUMANIGEN (TP Under review) | EUA application for lenzilumab is declined by the FDA at this time by Bryan Garnier
- Golar LNG - Weak prospects to weigh on Golar LNG share price by Drewry Maritime Equity Research
- OSE IMMUNO (CORPORATE, TP EUR17) | FR104 scores a licensing deal with Veloxis Pharmaceuticals: by Bryan Garnier
- TRANSGENE (CORPORATE, TP EUR3.2) | BT-001 goes to the Far West: by Bryan Garnier
- POXEL: Poxel to accelerate in rare disease | CORPORATE | EUR14.8 (+129%) by Bryan Garnier
- OSE IMMUNO: Positive 2021 outlook with anticipated advancements of the lead clinical programmes | CORPORATE | EUR17 (+33%) by Bryan Garnier
- KERING: As expected, Gucci should catch up in Q1 | BUY | EUR650 VS. EUR640 (+8%) by Bryan Garnier
- Smart Fit Discloses November 2021 Operational KPIs by Itau
- Nippon Prologis Placement by Aequitas Research
- OSE IMMUNO (CORPORATE, TP EUR17) | Anticipating 6-months data to decide the future of CoVepiT in 1Q22 by Bryan Garnier
- PIXIUM VISION (CORPORATE, TP EUR3,4) | A new patient implanted in the PRIMAvera study by Bryan Garnier
- TELECOM ITALIA (NEUTRAL, TP EUR0.4) | Vivendi changes position on network, reshuffling the cards by Bryan Garnier
- AB INBEV - BUY | EUR65 (+25%) Investor day feedback: a future of more cheers? by Bryan Garnier
- Itaú BBA on Infracommerce: Black Friday Operations Meet Guidance by Itau
- TELECOM ITALIA (NEUTRAL, TP EUR0.4) | Removal of Gubitosi highlights Vivendi’s influence: by Bryan Garnier
- NOVARTIS: Uninspiring future for the next 4 years | NEUTRAL vs. BUY | CHF85 VS. CHF115 (+14%) by Bryan Garnier
- Net Protections Holdings IPO by Aequitas Research
- SANOFI: Vaccines division outlook remains bright | BUY | EUR112 by Bryan Garnier
- Net Protections Holdings IPO by Aequitas Research
- EUROFINS SCIENTIFIC (NEUTRAL, TP EUR125) | New test to detect SARS-Cov-2 variant B.1.1529: by Bryan Garnier
- SOFTWARE AG: The case for private equity as the exit | BUY | EUR52 (+31%) by Bryan Garnier
- Net Protections Holdings IPO by Aequitas Research
- ADYEN (BUY, TP EUR2,900) | eBay acquires 1.25% of Adyen by exercising the first tranche of its warrants by Bryan Garnier
- INNATE PHARMA (BUY, TP EUR12) | ESMO-IO abstract release suggests to wait for presentation by Bryan Garnier
- MISTER SPEX (BUY, TP EUR30) | Mister Spex reaches its minimum target of store openings for 2021 by Bryan Garnier